Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Non Small Cell Lung CancerMetastatic Non Small Cell Lung CancerNSCLCMetastatic NSCLC - Non-Small Cell Lung Cancer
Interventions
PROCEDURE

Core Needle or Forceps Biopsy

Subjects must be clinically able, at investigator discretion, to undergo additional core needle or forceps biopsy passes during their biopsy. These additional biopsies may either be collected from the primary tumor or a metastatic site amenable to additional passes (e.g., liver or lymph nodes) per the clinician.

Trial Locations (7)

11967

NOT_YET_RECRUITING

New York Cancer & Blood Specialists, Shirley

21702

RECRUITING

James M Stockman Cancer Institute, Frederick

27599

TERMINATED

University of North Carolina at Chapel Hill, Chapel Hill

44718

TERMINATED

Gabrail Cancer Center, Canton

76104

RECRUITING

JPS Health Network, Fort Worth

76508

RECRUITING

Baylor Scott & White Research Institute, Temple

90095

NOT_YET_RECRUITING

UCLA Medical Center, Los Angeles

All Listed Sponsors
lead

Elephas

INDUSTRY